Blood activity of 125-I-fibrinogen in venous thrombosis

Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL.

Molecular and cellular biology·2010

Positive regulation of apoptosis by HCA66, a new Apaf-1 interacting protein, and its putative role in the physiopathology of NF1 microdeletion syndrome patients.

Cell death and differentiation·2007

Different cell thresholds for commitment to death: a link between carcinogenesis and drug resistance.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006

Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment.

Oncogene·2006

Cell cycle specific induction of HL-60 cell differentiation and apoptosis by mycophenolic acid.

Cell death and differentiation·2006

Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak.

Oncogene·2001

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Jugulotympanic paraganglioma, preoperative embolization, and transmastoid retrolabyrinthine approach: Two-dimensional operative video.

Surgical neurology international·2026

Immunosenescence in tumor progression: from synergistic mechanisms to therapeutic strategies.

Critical reviews in oncology/hematology·2026

The impact of intratumor heterogeneity on outcome and resistance to therapy in primary breast cancer: a systematic review.

Medical oncology (Northwood, London, England)·2026

CAR T cell-induced interferon gamma enhances MHC class I expression and sensitizes neuroblastoma to TCR-engineered T cell therapy.

Frontiers in immunology·2026

Noninvasive immune-inflammatory profiling by ultrasound radiomics for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma.

Frontiers in immunology·2026

Non-immune regulation of tertiary lymphoid structures in cancer.

Frontiers in immunology·2026

Related Experiment Videos

Blood activity of 125-I-fibrinogen in venous thrombosis

Related Concept Videos

Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL.

Positive regulation of apoptosis by HCA66, a new Apaf-1 interacting protein, and its putative role in the physiopathology of NF1 microdeletion syndrome patients.

Different cell thresholds for commitment to death: a link between carcinogenesis and drug resistance.

Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment.

Cell cycle specific induction of HL-60 cell differentiation and apoptosis by mycophenolic acid.

Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Jugulotympanic paraganglioma, preoperative embolization, and transmastoid retrolabyrinthine approach: Two-dimensional operative video.

Immunosenescence in tumor progression: from synergistic mechanisms to therapeutic strategies.

The impact of intratumor heterogeneity on outcome and resistance to therapy in primary breast cancer: a systematic review.

CAR T cell-induced interferon gamma enhances MHC class I expression and sensitizes neuroblastoma to TCR-engineered T cell therapy.

Noninvasive immune-inflammatory profiling by ultrasound radiomics for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma.

Non-immune regulation of tertiary lymphoid structures in cancer.

Related Experiment Videos

Blood activity of 125-I-fibrinogen in venous thrombosis

Related Concept Videos

Related Articles